INTRODUCTION: Fluoxetine is an antidepressant that has anti-inflammatory and antihyperalgesic effects in experimental models of pain and inflammation. The AIM of the present study was to determine the role of 5-HT2 receptors in the mechanism of anti-inflammatory and antihyperalgesic action of fluoxetine after single and repeated administration of the drug. MATERIALS AND METHODS: 40 male Wistar rats were randomly divided in five groups (n = 8) treated for 14 days with saline (control), diclofenac (positive control), fluoxetine, cyproheptadine (5-HT2 antagonist), and fluoxetine + cyproheptadine, respectively. We used the experimental model of inflammation induced by intraplantar injection of carrageenan and nociceptive test with mechanical pressure on the inflamed hind paw. RESULTS: Single and repeated administration of fluoxetine showed that it had significant anti-inflammatory and antihyperalgesic effects when compared with the control (p < 0.05). Cyproheptadine did not change significantly the anti-inflammatory effect of fluoxetine in the first 4 hours, after a single administration. At 24 hours the combination did not differ statistically when compared with the control. Cyproheptadin did not change significantly the anti-inflammatory effect of fluoxetine after repeated administration. After prolonged treatment the group that received fluoxetine + cyproheptadine showed a statistically significant increase in paw pressure to withdraw the hind paw compared with that treated with fluoxetine alone (p < 0.05). CONCLUSIONS: Fluoxetine has anti-inflammatory and antihyperalgesic effects in the carrageenan model of inflammation. 5-HT2 receptor mediated its anti-inflammatory effect in single dose treated animals. Spinal 5-HT2 receptors are involved in the antihyperalgesic effect of fluoxetine after repeated administration
If the inline PDF is not rendering correctly, you can download the PDF file here.
1. Sghendo L Mifsud J. Understanding the molecular pharmacology of the serotonergic system: using fl uoxetine as a model. J Pharm Pharmacol 2012;64(3):317-25.
2. Abdel-Salam OM Baiuomy AR Arbid MS. Studies on the anti-infl ammatory effect of fl uoxetine in the rat. Pharmacol Res 2004;49(2):119-31.
3. Maes M Yirmyia R Noraberg J Brene S et al. The infl ammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression. Metab Brain Dis 2009;24(1):27-53.
4. Altschuler EL Kast RE. Bupropion in psoriasis and atopic dermatitis: decreased tumor necrosis factoralpha? Psychosom Med 2003;65(4):719.
5. Singh VP Jain NK Kulkarni SK. On the antinociceptive effect of fl uoxetine a selective serotonin reuptake inhibitor. Brain Res 2000;915(2):218-26.
6. Ozdemir E Bagcivan I Gursoy S Altun A Durmus N. Effects of fl uoxetine and LY 367265 on tolerance to the analgesic effect of morphine in rats. Acta Physiol Hung 2011;98(2):205-13.
7. Zhao ZQ Chiechio S Sun YG Zhang KH et al. Mice lacking central serotonergic neurons show enhanced infl ammatory pain and an impaired analgesic response to antidepressant drugs. J Neurosci 2007;27:6045-53.
8. Sasaki M Obata H Kawahara K Saito S Goto F. Peripheral 5-HT2A receptor antagonism attenuates primary thermal hyperalgesia and secondary mechanical allodynia after thermal injury in rats. Pain 2006;122(1-2):130-6.
9. Abdel-Salam OM Nofal SM El Shenawy SM. Evaluation of the anti-infl ammatory and anti-nociceptive effects of different antidepressants in the rat. Pharmacol Res 2003;48(2):157-65.
10. Maleki N Nayebi AM Garjani A. Effects of central and peripheral depletion of serotonergic system on carrageenan-induced paw oedema. Int Immunopharmacol 2005;5(12):1723-30.
11. Jorgensen HS. Studies on the neuroendocrine role of serotonin. Dan Med Bull 2007;54(4):266-88.
12. Huang J Fan Y Jia Y Hong Y. Antagonism of 5-HT(2A) receptors inhibits the expression of pronociceptive mediator and enhances endogenous opioid mechanism in carrageenan-induced infl ammation in rats. Eur J Pharmacol 2011;654(1):33-41.
13. Sanchez C Hyttel J. Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding. Cell Mol Neurobiol 1999;19:467-89.
14. Le Bars D Gozariu M Cadden SW. Animal models of nociception. Pharmacol Rev 2001;53(4):597-652.
15. Sasaki M Obata H Saito S Goto F. Antinociception with intrathecal α-methyl-5-hydroxytryptamine a 5-hydroxytryptamine 2A/2C receptor agonist in two rat models of sustained pain. Anesth Analg 2003;96(4):1072-8.
16. Griffi ths JL Lovick TA. Co-localization of 5-HT2Areceptor- and GABA immunoreactivity in neurones in the periaqueductal grey matter of the rat. Neurosci Lett 2002;326(3):151-4.
17. Wang YY Wei YY Huang J Wang W et al. Expression patterns of 5-HT receptor subtypes 1A and 2A on GABAergic neurons within the spinal dorsal horn of GAD67-GFP knock-in mice. J Chem Neuroanat 2009;38:75-81.
18. Li H Lang B Kang JF Li YQ. Serotonin potentiates the response of neurons of the superfi cial laminae of the rat spinal dorsal horn to gamma-aminobutyric acid. Brain Res Bull 2000;52(6):559-65.
19. Pichon X Wattiez AS Becamel C Ehrlich I Bockaert J Eschalier A Marin P Courteix C. Disrupting 5-HT(2A) receptor/PDZ protein interactions reduces hyperalgesia and enhances SSRI effi cacy in neuropathic pain. Mol Ther 2010;18(8):1462-70.